About Methyl Drostanolone Magnus Pharmaceuticals
Methyl Drostanolone is a 17α-methylated derivative of drostanolone (masteron) designed for enhanced oral bioavailability in preclinical studies. This anabolic steroid exhibits potent androgenic binding properties and demonstrates tissue-selective anabolic activity in laboratory models. Magnus Pharmaceuticals has formulated this compound as precisely dosed 10mg tablets, enabling consistent analytical protocols across research programmes. The methylation at the C17 position provides metabolic stability, making it particularly valuable for Stroid UK Shop and receptor binding mechanisms.
Research Applications
Scientific investigations focus on methyl drostanolone’s unique molecular profile and its interactions with androgen receptor pathways. Laboratory studies examine its DHT-derived structure and assess binding affinity patterns compared to parent compounds. Research protocols investigate the compound’s resistance to aromatisation, making it valuable for studies examining non-estrogenic anabolic pathways. Comparative analysis with other methylated steroids reveals distinct pharmacological characteristics. Additional research explores tissue-specific gene expression modulation and protein synthesis markers. Some studies compare its activity profile with selective androgen receptor modulators to understand receptor selectivity patterns. Cross-referencing with peptide research provides comprehensive endocrine system insights.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Methyl Drostanolone (Superdrol) |
| Concentration | 10mg per tablet |
| Manufacturer | Magnus Pharmaceuticals |
| Formulation | Oral tablets |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Storage | Room temperature, dry conditions |
Research Compliance
This methyl drostanolone preparation is manufactured exclusively for in-vitro laboratory research and analytical purposes. The product is not intended for human consumption, clinical applications, or any form of therapeutic use. All research must comply with institutional ethics guidelines and local regulations governing controlled substances. Proper laboratory safety protocols, including appropriate personal protective equipment and ventilation systems, are mandatory when handling this compound. Researchers must maintain detailed documentation of all experimental procedures and disposal methods according to institutional waste management protocols.
